Standard of Care for Haemophilia A ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
288	Autoimmune acquired coagulation factor deficiency	1

288. Autoimmune acquired coagulation factor deficiency

---

Clinical trials : 205 /  Drugs : 238 - (DrugBank : 31) / Drug target genes : 18 - Drug target pathways : 26

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04165135 (ClinicalTrials.gov)	February 24, 2020	31/10/2019	An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment	A Multicenter, Non-Interventional Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Patients With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment	Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor;Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor;Haemophilia A	Drug: Standard of Care for Haemophilia A	Hoffmann-La Roche	NULL	Active, not recruiting	12 Years	50 Years	All	107		Italy